It really is concluded that EAM-2201 has the potential to bring about in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and is particularly evaluated in pooled human liver microsomes. Possible metabolites in the cannabimimetic agent JWH-018 had been synthesised, characterised to probe fo